The use of DNA viruses as vectors for gene therapy

Gene Therapy

Volumn 1, Issue 6, 1994, Pages 367-384

  Ali, Munaf ^a   Lemoine, Nicholas R ^a   Ring, Christopher J A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANIMAL; DNA VECTOR; DNA VIRUS; GENE THERAPY; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; PARVOVIRUS; REVIEW;

ADENOVIRIDAE; ANIMAL; DEPENDOVIRUS; DNA VIRUSES; GENE THERAPY; GENETIC VECTORS; HUMAN; PARVOVIRUS; SIMPLEXVIRUS;

EID: 0028533960     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (179)

1. Rosenberg, S.A., Aebersold, P., Cornetta, K. et al. Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumour-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 326, 370-378 (1990).
2. Le Gal La Salle, G., Robert, J.J., Berrard, S. et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990 (1993).
3. Jaffe, H.A., Danel, C., Longenecker, G. et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1, 372-378 (1992).
4. Rosenfeld, M.A., Yoshimura, K., Trapnell, B.C. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155 (1992).
5. Ginsberg, H.S. The Adenoviruses. Plenum Press: New York, 1984.
6. Horwitz, M.S. Adenoviridae and their replication. In: Virology. Fields, B.N., Knipe, D.M. et al. (eds). Raven Press: New York, 1990, pp. 1679-1721.
7. Graham, F.L. & Prevec, L. Manipulation of adenovirus vectors. In: Methods in Molecular Biology. Murray, E.J. (ed.). The Humana Press: Clifton, NJ, USA, 1991, pp. 109-128.
8. Hearing, P., Samulski, R.J., Wishart, W.L. & Shenk, T.J. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol 61, 2555-2558 (1987).
9. Straus, S.E. Adenovirus infections in humans. In: The Adenoviruses. Ginsberg, H.S. (ed.). Plenum Press: New York, 1984, pp. 451-496.
10. Rubin, B.A. & Rorke, L.B. Adenovirus vaccines. In: Vaccines. Plotkin, S.A. & Mortimer, E.A. (eds). W.B. Saunders: Philadelphia, PA, USA, 1988, pp. 492-512.
11. Grand, R.J.A. The structure and functions of the adenovirus early region 1 proteins. Biochem J 241, 25-38 (1987).
12. Jones, N. & Shenk, T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci USA 76, 3665-3669 (1979).
13. Wold, W.S.M. & Gooding, L.R. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interaction. Virology 184, 1-8 (1991).
14. Kelly, T.J. & Lewis, A.M. Use of non-defective adenovirussimian virus 40 hybrids for mapping the SV40 genome. J Virol 12, 643-652 (1973).
15. O'Connor, R.J. & Hearing, P. The C-terminal 70 amino acids of the adenovirus E4-ORF6/7 protein are essential and sufficient for E2F complex formation. Nucl Acids Res 19, 6579-6586 (1991).
16. Seth, P., Fitzgerald, D., Willingham, M. & Pastan, I. Pathway of adenovirus entry into cells. Mol Cell Biol 4, 1528-1533 (1984).
17. Michael, S.I. & Curiel, D.T. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Therapy 1, 223-232 (1994).
18. Flint, S.J. Adenovirus cytopathology. Comp Virol 19, 297-358 (1984).
19. Schneider, R.J. & Shenk, T. Impact of virus infection on host cell protein synthesis. Annu Rev Biochem 56, 317-332 (1987).
20. Van Ormondt, H. & Galibert, F. Nucleotide sequences of adenovirus DNAs. Curr Top Microbiol Immunol 110, 73-142 (1984).
21. Chroboczek, J. Bieber, F. & Jacrot, B. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186, 280-285 (1992).
22. Berkner, K.L. Development of adenoviral vectors for the expression of heterologous genes. Biotechniqnes 6, 616-624 (1988).
23. Kalicharran, K.K., Springthorpe, S. & Sattar, S.A. Studies on the stability of a human adenovirus-rabies recombinant vaccine. Can J Vet Res 56, 28-33 (1992).
24. Hsu, K.L., Lubeck, M.D., Davis, A.R. et al. Immunogenicity and protective efficacy of adenovirus vectored respiratory syncytial virus vaccine. Vaccine 91, 293-297 (1991).
25. Johnson, D.C., Ghosh-Chowdury, G., Smiley, J.R., Fallis, L. & Graham, F.L. Abundant expression of herpes simplex virus glycoprotein gb using an adenovirus vector. Virology 164, 1-14 (1988).
26. Morin, J.E., Lubeck, M.D., Barton, J.E., Conely, A.J., Davies, A.R., & Hung, P.P. Recombinant adenovirus induces antibody response to hepatitis B surface antigen in hamsters. Proc Natl Acad Sci USA 84, 4626-4630 (1987).
27. Prevec, L., Schneider, M., Rosenthal, K.L., Belbeck, L.W., Derbyshire, J.B. & Graham, F.L. Use of human adenovirus-based vectors for antigen expression in animals. J Gen Virol 70, 429-134 (1989).
28. Both, G.W., Lockett, L.J., Janardhana, V. et al. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193, 940-950 (1993).
29. Gorziglia, M.K. & Kapikan, A.Z. Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant. J Virol 66, 4407-4412 (1992).
30. Jacobs, S.C., Stephenson, J.R. & Wilkinson, G.W.G. High level expression of the Tick-borne encephalitis virus NS1 protein using an adenovirus-based vector: Protection elicited in a murine model. J Virol 66, 2086-2095 (1992).
31. Dewar, R.L., Natarajan, V., Vasudevachari, M.B. & Salzman, N.P. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol 63, 129-136 (1989).
32. Prevec, L., Christie, B.S., Laurie, K.E., Bailey, M.M., Graham, F.L. & Rosenthal, K.L. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. J Aquired Immun Defic Syndromes 4, 568-576 (1991).
33. Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59-74 (1977).
34. Ghosh-Choudhury, G., Haj-Ahmed, Y. & Graham, F.L. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full-length genomes. EMBO J 6, 1733-1739 (1987).
35. Bett, A.J., Prevec, L. & Graham, F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67, 5911-5921 (1993).
36. Thimmappaya, B., Jones, N. & Shenk, T. A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell 18, 947-954 (1979).
37. Shenk, T. & Williams, J. Genetic analysis of adenoviruses. Curr Top Microbiol Immunol 111, 1-39 (1984).
38. Stratford-Perricaudet, L.D., Levero, M., Chase, J.F., Perricaudet, M.& Briand, P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1, 241-256 (1990).
39. 1-antitrypsin using a recombinant adenovirus vector. FEBS Let 267, 60-62 (1990).
40. McGrory, W.J., Bautista, D.S. & Graham, F.L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617 (1988).
41. Stratford-Perricaudet, L.D., Makeh, I., Perricaudet, M. & Briand, P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90, 626-630 (1992).
42. Quantin, B., Perricaudet, L.D., Tajbakhsh, S. & Mandel, J.-L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 89, 2581-2584 (1992).
43. Wilkinson, G.W.G. & Akrigg, A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20, 2233-2239 (1992).
44. Lee, S.W., Trapnell, B.C., Rade, J.J., Virmani, R. & Dichek, D.A. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 73, 797-807 (1993).
45. Herz, J. & Gerard, R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 90, 2812-2816 (1993).
46. Kass-Eisler, A., Falck-Pedersen, E., Alvira, M. et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 90, 11498-11502 (1993).
47. Mittel, S.K., McDermott, M.R., Johnson, D.C., Prevec, L. & Graham, F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res 28, 67-90 (1993).
48. Yang, Y., Raper, S.E., Cohn, J.A., Engelhardt, J.F. & Wilson, J.M. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci USA 90, 4601-4605 (1993).
49. Rich, D.P., Couture, L.A., Cardoza, L.M. et al. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 4, 461-467 (1993).
50. Morsy, M.A., Alford, E.L., Bett, A., Graham, F.L. & Caskey, C.T. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J Clin Invest 92, 1580-1586 (1993).
51. Bacchetti, S. & Graham, F.L. Inhibition of cell proliferation by an adenovirus vector expressing the human wild type p53 protein. Int J Oncol 3, 781-788 (1993).
52. Zhang, W.-W., Fang, X., Mazur, W., French, B.A., Georges, R.N. & Roth, J.A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenoviruses. Cancer Gene Therapy 1, 5-13 (1994).
53. Haddada, H., Ragot, T., Cordier, L., Duffour, M.T. & Perricaudet, M. Adenoviral interleukin-2 gene transfer into P815 tumour cells abrogates tumourigenicity and induces immunity in mice. Hum Gene Ther 4, 703-711 (1993).
54. Vincent, N., Ragot, T., Gilgenkrantz, H. et al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet 5, 130-134 (1993).
55. Ragot, T., Vincent, N., Chafey, P. et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650 (1993).
56. Smith, T.A.G., Mehaffey, M.G., Kayda, D.B. et al. Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5, 397-402 (1993).
57. Kay, M.A., Landen, C.N., Rothenberg, S.R. et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in haemophilia B dogs. Proc Natl Acad Sci USA 91, 2353-2357 (1994).
58. Erzurum, S.C., Lemarchand, P., Rosenfeld, M.A., Yoo, J.-H. & Crystal, R.G. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucl Acids Res 21, 1607-1612 (1993).
59. Kolls, J., Peppel, K., Silva, M. & Beutler, B. Prolonged and effective blockade of tumour necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 91, 215-219, (1994).
60. Kozarsky, K., Grossman, M. & Wilson, J.M. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolaemia. Som Cell Mol Genet 19, 449-458 (1993).
61. Karlsson, S., Van Doren, K., Schweiger, S.G., Nienhuis, A.W. & Gluzman, Y. Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors. EMBO J 5, 2377-2385 (1986).
62. Chen, S.-H., Shine, H.D., Goodman, J.C., Grossman, R.G. & Woo, S.L.C. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91, 3054-3057 (1994).
63. Smythe, W.R., Hwang, H.C., Amin, K.M. et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: An effective in vitro drug sensitization system. Canc Res 54, 2055-2059 (1994).
64. Fujiwara, T., Grimm, E.A., Mukhopadhyay, T., Zhang, W.-W., Owen-Schaub, L.B. & Roth, J.A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Canc Res 54, 2287-2291 (1994).
65. Zabner, J., Couture, L.A., Gregory, R.J., Graham, S.M., Smith, A.E. & Welsh, M.J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216 (1993).
66. Mastrangeli, A., Danel, C., Rosenfeld, M.A. et al. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest 91, 225-234 (1993).
67. Zabner, J., Petersen, D.M., Puga, A.P. et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 6, 75-83 (1994).
68. Engelhardt, J.F., Yang, Y., Stratford-Perricaudet, L.D. et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with El-deleted adenoviruses. Nat Genet 4, 27-34 (1993).
69. Davidson, B.L., Allen, E.D., Kozarsky, K.F., Wilson, J.M. & Roessler, B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 3, 219-223 (1993).
70. Akli, S., Caillaud, C., Vigne, E. et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3, 224-228 (1993).
71. Bajocchi, G., Feldman, S.H., Crystal, R.G. & Mastrangeli, A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 3, 229-234 (1993).
72. Li, Q., Kay, M.A., Finegold, M., Stratford-Perricaudet, L.D. & Woo, S.L.C. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 4, 403-409 (1993).
73. Mashhour, B., Couton, D., Perricaudet, M. & Briand, P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther 1, 122-126 (1994).
74. Roessler, B.J., Allen, E.D., Wilson, J.M., Hartman, J.W. & Davidson, B.L. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 92, 1085-1092 (1993).
75. Haddada, H., Lopez, M., Martinache, C., Ragot, T., Abina, M.A. & Perricaudet, M. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Comm 195, 1174-1183 (1993).
76. 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci USA 89, 6482-6486 (1992).
77. Guzman, R.J., Lemarchand, P., Crystal, R.G., Epstein, S. & Finkel, T. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 88, 2838-2848 (1993).
78. 1-anti-trypsin gene to the lung epithelium in vivo. Science 252, 431-434 (1991).
79. Rosenfeld, M.A., Chu, C.-S., Seth, P. et al. Gene transfer to freshly isolated human resiratory epithelial cells in vitro using replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 5, 331-342 (1994).
80. Engelhardt, J.F., Simon, R.H., Yang, Y. et al. Adenovirus-mediated transfer of the CFTR gene to lung of non-human primates: biological efficacy study. Hum Gene Ther 4, 759-769 (1993).
81. Simon, R.H., Engelhardt, J.F., Yang, Y. et al. Adenovirus-mediated transfer of the CFTR gene to lung of non-human primates: toxicity study. Hum Gene Ther 4, 771-780 (1993).
82. Transcript of the October 25, 1993 meeting of the Vaccines Advisory Committee of the US FDA, available from the Center for Biologies, PDA, Bethesda, MD 20205, USA.
83. Yei, S., Mittereder, N., Tang, K., O'Sullivan, C. & Trapnell, B.C. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1, 192-200 (1994).
84. Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gönczöl, E. & Wilson, J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91, 4407-4411 (1994).
85. Engelhardt, J.F., Ye, X., Doranz, B. & Wilson, J.M. Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91, 6196-6200 (1994).
86. Yang, Y., Nunes, F.A., Berencsi, K., Gönczöl, E., Engelhardt, J.F. & Wilson, J.M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 7, 362-369 (1994).
87. Ginsberg, H.S., Lundholm-Beauchamp, U., Horswood, R.L. et al. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 86, 3823-3827 (1989).
88. Armentano, D., Sookdeo, C., White, G. et al. Second generation adenovirus vectors for cystic fibrosis gene therapy. J Cell Biochem ISA (Suppl.): (abstract no. DZ102) (1994).
89. Mann, R., Mulligan, R.L.& Baltimore, D. Construction of retrovirus packaging mutant 1 and its use to produce helper-free defective retrovirus. Cell 33, 153-159 (1983).
90. Weiss, R., Teich, N., Varmus, H.& Coffin, J. RNA Tumour Viruses. Cold Spring Harbor Laboratory: New York, 1985.
91. Stevens, J.G. Latent herpes virus simplex and the nervous system. Curr Top Microbiol Immunol 70, 31-50 (1975).
92. Post, L.E., Mackem, S.& Roizman, B. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene products. Cell 24, 555-565 (1981).
93. Spaete, R.R. & Frenkel, N. The herpes simplex virus amplicon: a new eukaryotic defective-virus cloning-amplifying vector. Cell 30, 285-304 (1982).
94. Stow, N.D.& McMonagle, E.C. Propagation of foreign DNA sequences linked to a herpes simplex virus origin of replication. In: Eukaryotic viral vectors. Gluzman,Y. (ed.). Cold Spring Harbor Laboratory: New York, 1982, pp. 199-204.
95. Kwong, A.D. & Frenkel, N. The herpex simplex amplicon: IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genome. Virology 142, 421-425 (1985).
96. Geller, A.L. & Breakefield, X.O. A defective HSV-1 vector expresses Eschericliia coli β-galactosidase in cultured peripheral neurons. Science 241, 1667-1669 (1988).
97. Geller, A.L. & Freese, A. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Eschericliia coli β-galactosidase. Proc Natl Acad Sci USA 87, 1149-1153 (1990).
98. Freese, A. & Geller, A.L. Infection of striatal neurons with a defective HSV-1 vector: implications for gene therapy. Nucleic Acids Res 19, 7219-7223.
99. During, M.J., Geller, A.L., Deutch, A.Y., Neve, R.L. & O'Malley, K. Expression of human tyrosine hydroxylase and unregulated signal transduction enzymes in neurons in the mammalian brain, from HSV-1 vectors. Abs Soc Neurosci 17, 56-58 (1991).
100. Kapitt, M.G., Pfaus, J.G., Kleopoulos, S.P., Hanlon, B.A., Rabkin, S.D. & Pfaff, D.W. Expression of a functional gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol Cell Neurosci 2, 320-330 (1991).
101. During, M.J., Geller, A.L., Deutch, A.Y.& O'Malley, K.L. Recovery in the rat 6-hydroxydopamine model of Parkinson's disease by direct intrastriatal injection of HSV-1 vectors which express the human tyrosine hydroxylase gene. Abs Soc Neurosci 18, 331-338 (1992).
102. Song, S., Hartley, D., Bryan, J. et al. Vector expressing an unregulated protein kinase C from the tyrosine hydroxylase promoter causes rotational behaviour following stereotactic injection into the substantia nigra of unlesioned rats. Abs Soc Neurosci 18, 363-380 (1992).
103. Harris, R.A., Everett, R.D., Zhu, X., Silverstein, S. & Preston, C.M. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J Virol 63, 3513-3515 (1989).
104. Geller, A.L., Keyomarski, K. Bryan, J. & Pardee, A.B. An efficient deletion mutant packaging system for defective HSV-1 vectors; potential applications to neuronal physiology and human gene therapy. Proc Natl Acad Sci USA 87, 8950-8954 (1990).
105. Deluca, N.A., MaCarthy, A.M. & Schaffer, P.A. Isolation and characterisation of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56, 558-570 (1985).
106. Rice, S. A. & Knipe, D. M. Genetic evidence for distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol 64, 1704-1715 (1990).
107. Sekulovich, R.E., Leary, K. & Sandri-Goldin, R.M. The herpes simplex virus type 1 a protein ICP27 can act as a trans-repressor or trans-activator in combination with ICP4 and ICPO. J Virol 62, 4510-4522 (1988).
108. Roizman, B. & Sears, A.E. Herpes simplex viruses and their replication. In: Virology. Fields, B.N. & Knipe, D.M. (ed.). Raven Press: New York, 1990, pp. 1795-1841.
109. Chalberg, M.D.& Kelly, T.J. Animal virus DNA replication. Ann Rev Biochem 58, 671-717 (1989).
110. Schrag, J.P., Peasad, B.V.V., Rixon, F.J. & Chiu, W. Three dimensional structure of the HSV-1 nucleocapsid. Cell 56, 651-660 (1989).
111. Cambel, M.E.M., Palfreyman, J.W. & Preston, C.M. Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate-early transcription. J Mol Biol 180, 1-19 (1984).
112. O'Hare, P.O. & Goding, C.Z. Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell 52, 435-445 (1988).
113. Rixon, F.J. & McLauchlan, J. Herpes simplex vectors. In: Molecular Virology: a Practical Approach. Davison, A.J. & Elliott, R.M. (eds). IRL Press: Oxford, 1993, pp. 285-307.
114. 3 molecular weight. Virology 139, 408-413 (1984).
115. Glorioso, J., Schroder, C.H., Kumel, G., Szczesiul, M. & Levine, M. Immunogenicity of herpes simplex glycoprotein gC and gB and their role in protective immunity. J Virol 50, 805-812 (1984).
116. Read, G.S. & Oroskar, A.A. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J Virol 63, 1897-1906 (1989).
117. Spivack, J.G.& Fraser, N.W. Detection of herpes simplex virus type I transcripts during latent infection in mice. J Virol 61, 3841-3847 (1987).
118. Frenkel, N., Spaete, R.R., Valzny, D.A., Deiss, L.P. & Locker, H. The herpes simplex virus amplicon: a novel animal-virus cloning vector. In: Eukaryotic Viral Vectors, 205-215. Gluczman,Y. (ed.). Cold Spring Harbor Laboratory: New York, 1982.
119. Spaete, R.R. & Frenkel, N. The herpes simplex virus amplicon: analysis of cis-acting replication functions. Proc Natl Acad Sci USA 82, 694-698 (1985).
120. Valzny, D.A. & Frenkel, N. Replication of herpes simplex virus DNA: localisation of replication recognition signals within defective virus genomes. Proc Natl Acad Sci USA 78, 742-746 (1981).
121. Valzny, D.A., Kwong, A. & Frenkel, N. Site-specific cleavage/packaging of herpes simplex virus DNA and selective maturation of nucleocapsids containing full length viral DNA. Proc Natl Acad Sci USA 79, 1423-1427 (1982).
122. Stow, N.D., McMonagle, B.C. & Davison, A.J. Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA. Nucleic Acids Res 11, 8205-8220 (1983).
123. Breakefield, X.O.& DeLuca, N.A. Herpes simplex virus for gene delivery to neurons. The New Biologist 3, 203-218 (1991).
124. Federoff, H.J., Geschwind, M.D., Geller, A.L. & Kessler, J.A. Expression of nerve growth factor in vivo from a defective herpes simplex virus type 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA 89, 1636-1640 (1992).
125. Leib, D.A. & Olivo, P.D. Gene delivery to neurons: is herpes simplex virus the right tool for the job? BioEssays 15, 547-554 (1993).
126. Palella, T.D., Hidaka, Y., Silverman, L.J., Levine, M., Glorioso, J.& Kelly, W.N. Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus type 1 vector. Gene 80, 137-144 (1989).
127. Palella, T.D., Silverman, L.J., Schroll, C.T., Homa, F.I., Levine, M.& Kelly, W.N. Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells. Mol Cell Biol 8, 457-460 (1988).
128. Cai, W. & Schaffer, P.A. Herpes simplex virus type 1 ICPO plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol 63, 4579-5489 (1989).
129. Ho, D.Y. & Mocarski, E.S. Beta-galactosidase as a marker in the peripheral and nervous tissues of the herpes simplex virus-infected mouse. Virology 174, 279-283 (1988).
130. Shih, M.-F., Arsenakis, P., Tiollais, P. & Roizman, B. Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha-and-beta-regulated gene chimeras. Proc Natl Acad Sci USA 81, 5867-5870 (1984).
131. Tackney, R.L., Cachianes, G. & Silverstein, S. Transduction of the Chinese hamster ovary aprt gene by herpes simplex virus. J Virol 52, 606-614 (1984).
132. Dobson, A.T., Margolis, T.P., Sedarati, F., Stevens, J.G. & Feldman, L.T. A latent, nonpathenogenic HSV-1 derived vector stably expresses beta-galactosidase in mouse neurons. Neurons 5, 353-360 (1990).
133. Shepard, A.A., Imbalzano, A.N. & DeLuca, N.A. Separation of primary structural components conferring autoregulation, transactivation and DNA-binding properties of the herpes simplex virus transcriptional regulatory protein ICP4. J Virol 63, 3714-3728 (1989).
134. Johnson, D.C.& Ligas, M.W. Herpes simplex virus lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. J Virol 62, 4605-4612 (1988).
135. Herz, C. & Roizman, B. The alpha promoter regulator ovalbumin chimeric gene resident in human cells is regulated like the authentic alpha 4 gene after infection with herpes simplex virus type 1 mutants in alpha 4 gene. Cell 33, 145-151 (1983).
136. Dobson, A.T., Sederati, F., Devi Rao, G. et al. Identification of the latency associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J Virol 63, 3844-3851 (1989).
137. Ho, D.Y. & Mocarski, E.S. Herpes simplex virus latent RNA (LAT) is not required for latent infection in mouse. Proc Natl Acad Sci USA 86, 7596-7600.
138. Desrosiers, R.C., Kamine, J., Bakker, A. et al. Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol Cell Biol 5, 2796-2803 (1985).
139. Chiocca, E.A., Choi, B.B., Cai, W., DeLuca, N.A., Schaffer, P.A., DiFiglia, M. et al. Transfer and expression of the LacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol 2, 739-746 (1990).
140. Fink, D.J., Sternberg, R.L., Weber, P.C., Mata, M., Goins, W.F. & Glorioso, J.C In vivo expression of β-galactosidase in hippocampal neurons by HSV-gene transfer. Hum Gene Ther 3, 11-19 (1992).
141. Johnson, P.A., Yoshida, K., Gage, F.H. & Friedman, T. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol Brain Sci 12, 95-101 (1992).
142. Ho, D.Y., Mocarski, E.S. & Supolsky, R.M. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci USA 90, 3655-3659 (1993).
143. Terry, R.D., Katzman, R. & Bick, K.L. (ed.). In: Alzheimer's Disease. Raven: New York, 1994.
144. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983 (1993).
145. Cotmore, S.R & Tattersall, P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 33, 91-169 (1987).
146. Berns, K.I. & Hauswirth, W.W. Adeno-associated virus DNA structure and replication. In: The Parvoviruses. Berns, K.I. (ed.). Plenum Publishing: New York, 1983, pp. 1-31.
147. Carter, B.J. & Laughlin, C.A. Adeno-associated virus defectiveness and the nature of the helper function. In: The Parvoviruscs. Berns, K.I. (ed.). Plenum Publishing: New York, 1983, pp. 67-127.
148. Schlehofer, J.R., Ehrbar, M. & zur Hausen, H. Vaccinia virus, herpes simplex virus and carcinogens induce DNA amplification in a human cell line and support replication of a helper virus dependent parvovirus. Virol 152, 110-117 (1986).
149. Hauswirth, W.W. Autonomous parvovirus DNA structure and replication. In: The Parvoviruses. Berns, K.I. (ed.). Plenum Publishing: New York, 1983, pp. 129-152.
150. Siegl, G. Biology and pathogenicity of autonomous parvoviruses. In: The Parvoviruses. Berns, K.I. (ed.). Plenum Publishing: New York, 1983, pp. 297-362.
151. Richards, R.G. & Armentrout, R.W. Early events in parvovirus replication: lack of integration by minute virus of mice into host cell DNA. J Virol 30, 379-399 (1979).
152. Majaniemi, I. & Siegl, G. Early events in the replication of parvovirus LuIII. Arc Virol 81, 285-302 (1984).
153. Ron, D. & Tal, J. Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L-cells. J Virol 55, 424-430 (1985).
154. Diffood, N., Chen, K.C., Bates, R.C. & Lederman, M. The complete nucleotide sequence of parvovirus LuIII and localisation of a unique sequence possibly responsible for its encapsidation pattern. Virology 192, 339-345 (1993).
155. Maxwell, I.H., Maxwell, F., Rhode III, S.L., Corsini, J. & Carlson, J.O. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum Gene Ther 4, 441-450 (1993).
156. Russell, S.J., Brandenburger, A., Flemming, C.L., Collins, M.K. & Rommelaere, J. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 66, 2821-2828 (1992).
157. Samulski, R.J., Berns, K.I., Tam, M.& Muzyczka, N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant virus in human cells. Proc Natl Acad Sci USA 79, 2077-2081 (1982).
158. Laughlin, C.A., Tratschin, J.D., Coon, H. & Carter, B.J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73 (1983).
159. Hermonat, P.L. & Muzyczak, N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81, 6466-6470 (1984).
160. Tratschin, J.D., West, M.H.P., Sandbank, T.& Carter, B.J. A human parvovirus, adeno-associated virus, as a eukaryotic vector: transient expression and encapsidation of the prokaryotic gene for chloroamphenicol acetlytransferase. Mol Cell Biol 4, 2072-2081 (1984).
161. Tratschin, J.D., Miller, I.L., Smith, M.G. & Carter, B.J. An adeno-associated virus vector for high frequency integration, expression and rescue of genes in mammalian cells. Mol Cell Biol 5, 3251-3260 (1985).
162. Kotin, R.M. & Berns, K.I. Organisation of adeno-associated virus DNA in latently Detroit 6 infected cells. Virology 170, 460-467 (1989).
163. Kotin, R.M., Siniscalo, M., Samulski, R.J. et al. Site specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87, 2211-2215 (1990).
164. Samulski, R.J., Zhu, X., Xiao, X. et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 10, 3941-3950 (1991).
165. Kotin, R.M., Menninger, J.C., Ward, D.C.& Berns, K.I. Mapping and direct visualisation of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10, 831-834 (1991).
166. Laughlin, C.A., Jones, N. & Carter, B.J. Effects of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus. J Virol 41, 868-876 (1982).
167. Trempe, J.P., Mendelson, E. & Carter, B.J. Characterisation of adeno-associated virus rep proteins in human cells by antibodies raised against rep expressed in Escherichia coli. Virology 161, 18-28 (1987).
168. Redemann, B.E., Mendelson, E. Carter, B.J. Adeno-associated virus Rep protein synthesis during productive infection. J Virol 63, 873-882 (1989).
169. Im, D.-S. & Muzyczka, N. The AAV origin binding protein REP68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61, 447-457 (1990).
170. Green, M.R. & Roeder, R.G. Definition of a novel promoter for the major adeno-associated virus mRNA. Cell 22, 231-242. (1980).
171. Tratschin, J.D., Miller, I.L. & Carter, B.J. Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol 51, 611-619 (1984).
172. McLaughlin, S.K., Collis, P., Hermonat, P.L. & Muzyczka, N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62, 1963-1973 (1988).
173. Samulski, R.J., Chang, L.-S. & Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63, 3822-3828 (1989).
174. Walsh, C.E., Johnson, M.L., Xiao, X., Young, N.S., Neinhuis, A.W. & Samulski, R. Regulated high level expression of a human γ-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 89, 7257-7261 (1992).
175. - channels by protein kinase A corrected by insertion of CFTR. Nature 358, 581-584 (1992).
176. Flotte, T.R., Afione, S.A., Solow, R. et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 268, 3781-3790 (1993).
177. Flotte, T.R., Afione, S.A., Conrad, C. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90, 10613-10617 (1993).
178. Ponnazhagan, S., Nallari, M.L. & Srivastava, A. Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based vectors. J Exp Med 179, 733-738 (1994).
179. Philip, R., Brunette, E., Kilinski, L. et al. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Biol 14, 2411-2418 (1994).